在中风患者的性管理中,内巴克洛芬注射的有效性:一个元分析
1Department of Rehabilitation Medicine, Gil Medical Center, Gachon University, Incheon, Korea.
Brain & NeuroRehabilitation
|April 8, 2024
概括
内巴克洛芬注射有效地治疗严重的性,并改善中风患者的步行速度,这些患者对传统疗法没有反应. 这种疗法需要仔细考虑个体患者的因素,以获得最佳的结果.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 内巴克洛芬注射用于在中风,脊髓损伤和中枢神经系统疾病等疾病中治疗性.
- 在性方面,巴克洛芬静脉注射的比较疗效仍在争论中.
研究的目的:
- 在成年中风患者中,系统地审查和元分析内内巴克洛芬注射对性和步行速度的疗效.
主要方法:
- 对3个数据库 (科克兰图书馆,MEDLINE,Embase) 的系统审查.
- 包括随机对照试验 (RCT) 和非随机研究,比较内巴克洛芬与其他干预措施.
- 使用Cochrane的RoB工具和ROBINS-I.使用偏差风险评估.
- 使用Revman 5.4和对建议,评估,开发和评估 (GRADE) 的评级来确定证据有效性的元分析.
主要成果:
- 分析包括2个RCT和7个非RCT用于性,以及4个非RCT用于步行速度.
- 静脉内巴克洛芬注射表明对减轻性有显著的积极影响.
- 随着内巴克洛芬注射,人们观察到步行速度的显著改善.
结论:
- 导管内巴克洛芬注射是一种潜在的治疗中风患者的严重性耐受常规治疗的治疗方法.
- 个体患者的特征和特殊情况应指导内巴克洛芬治疗的决策过程.
更多相关视频
相关概念视频
Drug Delivery: Parenteral Route
507
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
507
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Centrally Acting Muscle Relaxants: Therapeutic Uses
675
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
675
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482
Local Anesthetics: Clinical Application as Spinal Anesthesia
623
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
623
Spasmolytic Agents: Chemical Classification
882
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
882


